BGM Group Ltd. SEC filings BGM
BGM Group Ltd. has 154 filings in SEC EDGAR's recent list, going back to Jun 17, 2019. Its latest annual report, Form 20-F, was filed on Jul 21, 2026 for the period ended Sep 30, 2025. The most recent current report (Form 6-K) was filed on Sep 24, 2026. The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Jul 21, 2026 | Sep 30, 2025 |
| 20-F/A | Amended annual report (foreign issuer) | May 8, 2025 | Sep 30, 2024 |
| 20-F/A | Amended annual report (foreign issuer) | Apr 3, 2025 | Sep 30, 2024 |
| 20-F/A | Amended annual report (foreign issuer) | Feb 6, 2025 | Sep 30, 2024 |
| 20-F | Annual report (foreign issuer) | Jan 27, 2025 | Sep 30, 2024 |
| 20-F | Annual report (foreign issuer) | Feb 15, 2024 | Sep 30, 2023 |
| 20-F | Annual report (foreign issuer) | Apr 19, 2023 | Sep 30, 2022 |
| 20-F/A | Amended annual report (foreign issuer) | Oct 13, 2022 | Sep 30, 2021 |
| 20-F/A | Amended annual report (foreign issuer) | Aug 1, 2022 | Sep 30, 2021 |
| 20-F/A | Amended annual report (foreign issuer) | Jun 30, 2022 | Sep 30, 2021 |
| 20-F | Annual report (foreign issuer) | Feb 11, 2022 | Sep 30, 2021 |
| 20-F/A | Amended annual report (foreign issuer) | Mar 9, 2021 | Sep 30, 2020 |
| 20-F | Annual report (foreign issuer) | Feb 11, 2021 | Sep 30, 2020 |
Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BGM (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- Cayman Islands
- Headquarters
- Chengdu
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1779578
- Former names
- Qilian International Holding Group (until Oct 22, 2024); Qilian International Holding Group Ltd (until Oct 16, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.